Azuma Kanatsuka
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Long-term effects of esaxerenone in patients with type 2 diabetes, diabetic kidney disease, and hypertension (JDDM77).
Journal: Diabetology international
Published: August 28, 2024
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Journal: BMJ open diabetes research & care
Published: December 15, 2021
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60).
Journal: Diabetology international
Published: March 22, 2021
Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59).
Journal: Journal of diabetes investigation
Published: November 15, 2020
Association of a SNP in the IAPP gene and hyperglycemia on β-cell dysfunction in type 2 diabetes: the Toon Genome Study.
Journal: Diabetology international
Published: October 25, 2020
Improved insulin sensitivity with sodium-glucose cotransporter 2 inhibitor treatment in a patient with slowly progressive type 1 diabetes mellitus with metabolic syndrome: a case report.
Journal: Diabetology international
Published: April 30, 2020
Correction to: IAPP/amylin and β‑cell failure: implication of the risk factors of type 2 diabetes.
Journal: Diabetology international
Published: January 04, 2019
IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes.
Journal: Diabetology international
Published: November 08, 2017
Relationship between kidney function decline and initial risk factors for the progression of diabetic kidney disease: a retrospective analysis of 91 Japanese patients with type 2 diabetes.
Journal: Diabetology international
Published: December 17, 2015
Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).
Journal: Journal of diabetes investigation
Published: May 27, 2015
The dipeptidyl peptidase-4 inhibitor vildagliptin has the capacity to repair β-cell dysfunction and insulin resistance.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: July 01, 2014
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.
Journal: Journal of diabetes investigation
Published: June 06, 2014
Last Updated: 09/26/2026